All stock lists
Corcept Therapeutics Inc (NASDAQ:CORT)
US · Delayed Price · Currency is USD
85.86-21.64 (-20.13%)
Insider Score
––Not scored
CORT Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
CORT Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 256.15 M | 164.90 M | 202.13 M | 207.64 M | 194.43 M | 157.21 M |
| Revenue Growth (YoY) | 31.74 % | 4.89 % | 11.12 % | 13.75 % | 18.70 % | 7.09 % |
| Cost of Revenue | 4.06 M | 2.88 M | 2.54 M | 4.60 M | 3.43 M | 2.40 M |
| Gross Profit | 252.09 M | 162.02 M | 199.58 M | 203.04 M | 191.00 M | 154.81 M |
| SG&A Expense | 156.90 M | 145.36 M | 130.24 M | 123.98 M | 103.85 M | 90.66 M |
| R&D Expense | 53.89 M | 66.27 M | 64.86 M | 68.85 M | 60.47 M | 60.73 M |
| Operating Expenses | 210.79 M | 211.62 M | 195.09 M | 192.82 M | 164.32 M | 151.40 M |
| Operating Income | 41.30 M | -49.60 M | 4.49 M | 10.22 M | 26.68 M | 3.42 M |
| Pretax Income | 45.93 M | -44.72 M | 9.91 M | 15.24 M | 31.69 M | 9.62 M |
| Tax Provision | -2.94 M | -13.51 M | -14.38 M | -4.42 M | -3.46 M | -10.93 M |
| Net Income | 42.14 M | -31.20 M | 24.29 M | 19.67 M | 35.15 M | 20.55 M |
| EPS (Basic) | 0.40 | -0.30 | 0.23 | 0.19 | 0.33 | 0.19 |
| EPS (Diluted) | 0.36 | -0.30 | 0.20 | 0.16 | 0.29 | 0.17 |
| Shares Outstanding | 105.38 M | 104.44 M | 103.69 M | 103.55 M | 104.11 M | 104.11 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.